The ACS Infectious Diseases journal has awarded Assistant Professor Anushree Chatterjee a 2018 Young Investigator Award.
The award is granted to three outstanding young investigators in the field of infectious diseases. Each award winner receives a plaque, $1,000 cash and a travel stipend to present their research as the ACS Fall National Meeting in Boston.
Chatterjee’s lab develops therapeutic approaches to combat drug-resistant superbugs and hard-to-treat bacterial infections. Her group uses a combination of approaches including synthetic biology, systems biology, synthetic chemistry, microbiology and nanoengineering. The team has developed a range of therapeutic platforms based on antisense peptide nucleic acids, CRISPR inhibition and quantum dot nanoparticles to address the key global challenge of infectious diseases.
Chatterjee joined the Department of Chemical and Biological Engineering in 2013. Prior to joining CU Boulder, she was a postdoctoral research fellow at the Theoretical Biology and Biophysics group at Los Alamos National Laboratory studying gene regulation of hepatitis C virus.
She earned a PhD in chemical engineering from the University of Minnesota and bachelor and master’s degrees in chemical engineering from the Indian Institute of Technology Delhi.
Chatterjee’s research has been featured by academic and federal institutions such as the Material Research Society, Faculty of 1000 and the National Science Foundation, as well as popular national and international media outlets including BBC, CGTN America, and Voice of America.